tirzepatide off label Mounjaro (tirzepatide), a dual GLP-1 and GIP agonist, was FDA-approved for Type 2 diabetes since 2022, is being used off-label for weight loss with remarkable results. Clinical trials demonstrated… CVS Caremark, why are you

Last updated July 14, 2026 Key takeaways The current FDA Wegovy label, revised February 2026, gives injectable semaglutide an elimination half-life of approximately 1 week

For example, a patient with a GIPR variant favoring robust GIP signaling may see stronger metabolic benefits from tirzepatide alone, while another with reduced GLP1R sensitivity might benefit from adding berberine to enhance glucose control

By Vaughn Vreeland As visitors flock to places like Mexico City, Milan and Copenhagen, residents are rethinking what they share, and whom they share it with

Why acidic formulas aren't bad for your skin Your skin is naturally slightly acidic and functions optimally at an acidic pH

Sumatras indigenous Batak people had depicted a lizard with a pointy horn at the end of its snout, like a rhinoceros, in their artwork for centuries, and it holds a prominent place in their creation stories

Women planning pregnancy should discuss appropriate timing of discontinuation with their healthcare provider based on their individual clinical situation